NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) | RFA DC 22 001

Opportunity Information: Apply for RFA DC 22 001

The NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional) opportunity (RFA-DC-22-001) is a National Institutes of Health discretionary grant designed to move strong basic research findings closer to real-world clinical use in areas tied to communication disorders. The main idea is to support translational projects where basic scientists, clinicians, and clinical scientists work together to turn foundational discoveries into practical clinical tools that can improve human health. Projects supported under this announcement are expected to do more than generate new knowledge; they must show a clear connection to a clinical condition and be aimed at outcomes that can realistically affect patient care, such as better diagnosis, treatment, or prevention strategies for disorders involving hearing, balance, taste, smell, voice, speech, or language.

The scope of the funding is intentionally broad as long as the work is genuinely translational and clinically meaningful. That can include taking established mechanisms, biomarkers, measurement approaches, devices, assays, or intervention concepts that were originally developed in basic or preclinical settings and adapting, refining, validating, or testing them so they can be used in clinical contexts. The emphasis is on producing deliverables that have practical clinical impact, meaning the proposed work should point toward tools clinicians or clinical researchers could actually use, not just theoretical models. Because the FOA is labeled "Clinical Trial Optional," applicants may propose studies that include clinical trials if that makes sense for their tool-development pathway, but a clinical trial is not required to be competitive; what matters is a credible plan to translate basic findings into usable clinical applications.

This is an R01 mechanism, which generally supports substantial, multi-year research projects and typically fits teams that can justify a defined translational objective with clear milestones. The activity category is Health, and the CFDA/Assistance Listing number associated with the program is 93.173. The original closing date listed for this opportunity is June 20, 2024, and the FOA record shows it was created on June 25, 2021. The award ceiling and expected number of awards are not specified in the provided source data, which usually means applicants need to consult the full FOA text and NIH budget guidelines for details on allowable costs, project period expectations, and any institute-specific caps or considerations.

Eligibility is expansive and includes a wide range of applicant organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, tribal governments other than federally recognized, and non-U.S. entities (foreign organizations). This breadth is intended to encourage participation from diverse institutions and communities and to support translational work that can reach varied populations and care settings.

In practical terms, a strong application under this FOA would clearly define the clinical need being addressed, explain the underlying basic science finding being translated, and lay out a realistic development and validation plan that ends with something clinically actionable. Reviewers are likely to look for credible interdisciplinary collaboration, a strong rationale for how the proposed tool will improve diagnosis, treatment, or prevention, and evidence that the project is positioned to move beyond basic discovery toward implementation-relevant outputs.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
• This funding opportunity was created on 2021-06-25.
• Applicants must submit their applications by 2024-06-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DC 22 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: